Maternal serum proteome changes between the first and third trimester of pregnancy in rural Southern Nepal

Placenta

Volumn 33, Issue 5, 2012, Pages 424-432

  Scholl, P F ^a,e   Cole, R N ^b   Ruczinski, I ^c   Gucek, M ^b   Diez, R ^b   Rennie, A ^a   Nathasingh, C ^a   Schulze, K ^d   Christian, P ^d   Yager, J D ^a   Groopman, J D ^a   West, K P ^d  

^a The Johns Hopkins University   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c Center for Human Nutrition   (United States)

^d Department of International Health ^*  (United States)

^e CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

DIGE; Gelsolin; iTRAQ; Maternal serum proteomics; Pregnancy proteins; Pregnancy specific glycoprotein 4

Indexed keywords

ALPHA 1B GLYCOPROTEIN; COMPLEMENT COMPONENT C1R; GELSOLIN; GLYCOPROTEIN; OROSOMUCOID; PLASMA PROTEIN; PREGNANCY SPECIFIC BETA GLYCOPROTEIN 4; UNCLASSIFIED DRUG;

ARTICLE; BLOOD PRESSURE REGULATION; CLINICAL ARTICLE; CYTOSKELETON; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; LIPID TRANSPORT; MATERNAL SERUM; NEPAL; NUTRITIONAL PARAMETERS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; RURAL AREA; SYNCYTIOTROPHOBLAST; THIRD TRIMESTER PREGNANCY;

BLOTTING, WESTERN; CHROMATOGRAPHY, LIQUID; FEMALE; HUMANS; MALNUTRITION; MASS SPECTROMETRY; NEPAL; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, THIRD; PROTEOME; RURAL POPULATION; TWO-DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS;

EID: 84859156032     PISSN: 01434004     EISSN: 15323102     Source Type: Journal    
DOI: 10.1016/j.placenta.2012.02.009     Document Type: Article

References (61)

1. N.L. Anderson, M. Polanski, R. Pieper, T. Gatlin, R.S. Tirumalai, and T.P. Conrads The human plasma proteome: a nonredundant list developed by combination of four separate sources Mol Cell Proteomics 3 4 2004 311 326
2. P. Hudler, M. Gorsic, and R. Komel Proteomic strategies and challenges in tumor metastasis research Clin Exp Metastasis 27 6 2010 441 451
3. Q. Fu, and J.E. Van Eyk Proteomics and heart disease: identifying biomarkers of clinical utility Expert Rev Proteomics 3 2 2006 237 249
4. R. Shankar, N. Gude, F. Cullinane, S. Brennecke, A.W. Purcell, and E.K. Moses An emerging role for comprehensive proteome analysis in human pregnancy research Reproduction 129 6 2005 685 696
5. P. Christian, K.P. West, S.K. Khatry, S.C. Leclerq, E.K. Pradhan, and J. Katz Effects of maternal micronutrient supplementation on fetal loss and infant mortality: a cluster-randomized trial in Nepal Am J Clin Nutr 78 6 2003 1194 1202
6. P. Christian, T. Jiang, S.K. Khatry, S.C. LeClerq, S.R. Shrestha, and K.P. West Jr. Antenatal supplementation with micronutrients and biochemical indicators of status and subclinical infection in rural Nepal Am J Clin Nutr 83 4 2006 788 794
7. K.P. West Jr., J. Katz, S.K. Khatry, S.C. LeClerq, E.K. Pradhan, and S.R. Shrestha Double blind, cluster randomised trial of low dose supplementation with vitamin A or beta carotene on mortality related to pregnancy in Nepal. The NNIPS-2 study group BMJ 318 7183 1999 570 575
8. J. Storey A direct approach to false discovery rates J R Statist Soc B 64 3 2002 479 498
9. A. Shevchenko, M. Wilm, O. Vorm, and M. Mann Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels Anal Chem 68 5 1996 850 858
10. C.M. Petersen Alpha 2-macroglobulin and pregnancy zone protein. Serum levels, alpha 2-macroglobulin receptors, cellular synthesis and aspects of function in relation to immunology Dan Med Bull 40 4 1993 409 446
11. L. Sottrup-Jensen, J. Folkersen, T. Kristensen, and B.F. Tack Partial primary structure of human pregnancy zone protein: extensive sequence homology with human alpha 2-macroglobulin Proc Natl Acad Sci U S A 81 23 1984 7353 7357
12. O. Sand, J. Folkersen, J.G. Westergaard, and L. Sottrup-Jensen Characterization of human pregnancy zone protein. Comparison with human alpha 2-macroglobulin J Biol Chem 260 29 1985 15723 15735
13. R.F. Ritchie, and G. Palomaki Selecting clinically relevant populations for reference intervals Clin Chem Lab Med 42 7 2004 702 709
14. P.O. Ganrot, and B. Bjerre Alpha-1-antitrypsin and alpha-2-macroglobulin concentration in serum during pregnancy Acta Obstet Gynecol Scand 46 2 1967 126 137
15. S.R. de Cordoba, and E.G. de Jorge Translational mini-review series on complement factor H: genetics and disease associations of human complement factor H Clin Exp Immunol 151 1 2008 1 13
16. J. Myron Effect of a new international reference preparation for proteins in human serum (certified reference material 470) on results of the college of American pathologists surveys for plasma proteins Arch Pathol Lab Med 124 2000 1496 1501
17. C. Oxvig, J. Haaning, L. Kristensen, J.M. Wagner, I. Rubin, and T. Stigbrand Identification of angiotensinogen and complement C3dg as novel proteins binding the proform of eosinophil major basic protein in human pregnancy serum and plasma J Biol Chem 270 23 1995 13645 13651
18. S. Miyakis, B. Giannakopoulos, and S.A. Krilis Beta 2 glycoprotein I-function in health and disease Thromb Res 114 5-6 2004 335 346
19. J. Masuda, K. Suzuki, A. Satoh, K. Kojima-Aikawa, K. Nakanishi, and K. Kuroda Beta-2-glycoprotein I and urinary trypsin inhibitor levels in the plasma of pregnant and postpartum women Thromb Res 117 3 2006 255 261
20. R. Pieper, C.L. Gatlin, A.J. Makusky, P.S. Russo, C.R. Schatz, and S.S. Miller The human serum proteome: display of nearly 3700 chromatographically separated protein spots on two-dimensional electrophoresis gels and identification of 325 distinct proteins Proteomics 3 7 2003 1345 1364
21. I.G. Palomo, F.M. Segovia, M.L. Alarcon, B.Y. Fuentes, J.G. Pereira, and A. Rojas An insight into the pathophysiology of thrombosis in antiphospholipid syndrome Front Biosci 12 2007 3093 3103
22. M. Honda, Y. Omori, S. Minei, T. Oshiyama, M. Shimizu, and M. Sanaka Quantitative analysis of serum alpha 1-acid glycoprotein levels in normal and diabetic pregnancy Diabetes Res Clin Pract 10 2 1990 147 152
23. G. Lippi, A. Albiero, M. Montagnana, G.L. Salvagno, S. Scevarolli, and M. Franchi Lipid and lipoprotein profile in physiological pregnancy Clin Lab 53 3-4 2007 173 177
24. S. Watanabe, and J.Y. Chou Isolation and characterization of complementary DNAs encoding human pregnancy-specific beta 1-glycoprotein J Biol Chem 263 4 1988 2049 2054
25. S. Teglund, G.Q. Zhou, and S. Hammarstrom Characterization of cDNA encoding novel pregnancy-specific glycoprotein variants Biochem Biophys Res Commun 211 2 1995 656 664
26. W.Y. Chan, Q.X. Zheng, J. McMahon, and L.A. Tease Characterization of new members of the pregnancy-specific beta 1-glycoprotein family Mol Cell Biochem 106 2 1991 161 170
27. N.A. Bersinger, D. Wunder, F. Vanderlick, A. Chanson, G. Pescia, and P. Janecek Maternal serum levels of placental proteins after in vitro fertilisation and their implications for prenatal screening Prenat Diagn 24 6 2004 471 477
28. S. Okazaki, A. Sekizawa, Y. Purwosunu, A. Farina, N. Wibowo, and T. Okai Placenta-derived, cellular messenger RNA expression in the maternal blood of preeclamptic women Obstet Gynecol 110 5 2007 1130 1136
29. O. Lapaire, W. Holzgreve, J.C. Oosterwijk, R. Brinkhaus, and D.W. Bianchi Georg Schmorl on trophoblasts in the maternal circulation Placenta 28 1 2007 1 5
30. S.R. Nagalla, J.A. Canick, T. Jacob, K.A. Schneider, A.P. Reddy, and A. Thomas Proteomic analysis of maternal serum in down syndrome: identification of novel protein biomarkers J Proteome Res 6 4 2007 1245 1257
31. V. Sitras, R.H. Paulssen, H. Gronaas, J. Leirvik, T.A. Hanssen, and A. Vartun Differential placental gene expression in severe preeclampsia Placenta 30 5 2009 424 433
32. J.E. Michaels, S. Dasari, L. Pereira, A.P. Reddy, J.A. Lapidus, and X. Lu Comprehensive proteomic analysis of the human amniotic fluid proteome: gestational age-dependent changes J Proteome Res 6 4 2007 1277 1285
33. D.J. Kwiatkowski, and H.L. Yin Molecular biology of gelsolin, a calcium-regulated actin filament severing protein Biorheology 24 6 1987 643 647
34. M.J. Dinubile Plasma gelsolin: in search of its raison d'etre. Focus on "Modifications of cellular responses to lysophosphatidic acid and platelet-activating factor by plasma gelsolin Am J Physiol Cell Physiol 292 4 2007 C1240 C1242
35. H.Q. Sun, M. Yamamoto, M. Mejillano, and H.L. Yin Gelsolin, a multifunctional actin regulatory protein J Biol Chem 274 47 1999 33179 33182
36. L. Spinardi, and W. Witke Gelsolin and diseases Subcell Biochem 45 2007 55 69
37. N. Montalbetti, Q. Li, G.A. Timpanaro, S. Gonzalez-Perrett, X.Q. Dai, and X.Z. Chen Cytoskeletal regulation of calcium-permeable cation channels in the human syncytiotrophoblast: role of gelsolin J Physiol 566 Pt 2 2005 309 325
38. D.J. Kwiatkowski, R. Mehl, S. Izumo, B. Nadal-Ginard, and H.L. Yin Muscle is the major source of plasma gelsolin J Biol Chem 263 17 1988 8239 8243
39. H.L. Yin, and T.P. Stossel Control of cytoplasmic actin gel-sol transformation by gelsolin, a calcium-dependent regulatory protein Nature 281 5732 1979 583 586
40. D.L. Emerson, P. Arnaud, and R.M. Galbraith Evidence of increased Gc: actin complexes in pregnant serum: a possible result of trophoblast embolism Am J Reprod Immunol 4 4 1983 185 189
41. E. Guetta, L. Gutstein-Abo, and G. Barkai Trophoblasts isolated from the maternal circulation: in vitro expansion and potential application in non-invasive prenatal diagnosis J Histochem Cytochem 53 3 2005 337 339
42. S.E. Lind, D.B. Smith, P.A. Janmey, and T.P. Stossel Role of plasma gelsolin and the vitamin D-binding protein in clearing actin from the circulation J Clin Invest 78 3 1986 736 742
43. P.S. Lee, S.R. Patel, D.C. Christiani, E. Bajwa, T.P. Stossel, and A.B. Waxman Plasma gelsolin depletion and circulating actin in sepsis: a pilot study PLoS One 3 11 2008 e3712
44. T.M. Osborn, M. Verdrengh, T.P. Stossel, A. Tarkowski, and M. Bokarewa Decreased levels of the gelsolin plasma isoform in patients with rheumatoid arthritis Arthritis Res Ther 10 5 2008 R117
45. S.E. Lind, D.B. Smith, P.A. Janmey, and T.P. Stossel Depression of gelsolin levels and detection of gelsolin-actin complexes in plasma of patients with acute lung injury Am Rev Respir Dis 138 2 1988 429 434
46. S. Dueland, M.S. Nenseter, and C.A. Drevon Uptake and degradation of filamentous actin and vitamin D-binding protein in the rat Biochem J 274 Pt 1 1991 237 241
47. J.G. Haddad, K.D. Harper, M. Guoth, G.G. Pietra, and J.W. Sanger Angiopathic consequences of saturating the plasma scavenger system for actin Proc Natl Acad Sci U S A 87 4 1990 1381 1385
48. W.M. Lee, and R.M. Galbraith The extracellular actin-scavenger system and actin toxicity N Engl J Med 326 20 1992 1335 1341
49. K.C. Mounzer, M. Moncure, Y.R. Smith, and M.J. Dinubile Relationship of admission plasma gelsolin levels to clinical outcomes in patients after major trauma Am J Respir Crit Care Med 160 5 Pt 1 1999 1673 1681
50. M.J. DiNubile Plasma gelsolin as a biomarker of inflammation Arthritis Res Ther 10 6 2008 124
51. C.W. Redman, and I.L. Sargent Circulating microparticles in normal pregnancy and pre-eclampsia Placenta 29 Suppl. A 2008 S73 S77
52. B. Huppertz, M. Kadyrov, and J.C. Kingdom Apoptosis and its role in the trophoblast Am J Obstet Gynecol 195 1 2006 29 39
53. R. Bucki, A. Kulakowska, F.J. Byfield, M. Zendzian-Piotrowska, M. Baranowski, and M. Marzec Plasma gelsolin modulates cellular response to sphingosine 1-phosphate Am J Physiol Cell Physiol 299 6 2010 C1516 C1523
54. D. Leiber, Y. Banno, and Z. Tanfin Exogenous sphingosine 1-phosphate and sphingosine kinase activated by endothelin-1 induced myometrial contraction through differential mechanisms Am J Physiol Cell Physiol 292 1 2007 C240 C250
55. Y. Yamamoto, D.M. Olson, M. van Bennekom, D.N. Brindley, and D.G. Hemmings Increased expression of enzymes for sphingosine 1-phosphate turnover and signaling in human decidua during late pregnancy Biol Reprod 82 3 2010 628 635
56. M. Serrano-Sanchez, Z. Tanfin, and D. Leiber Signaling pathways involved in sphingosine kinase activation and sphingosine-1-phosphate release in rat myometrium in late pregnancy: role in the induction of cyclooxygenase 2 Endocrinology 149 9 2008 4669 4679
57. A. Kolialexi, G.T. Tsangaris, N. Papantoniou, A.K. Anagnostopoulos, K. Vougas, and V. Bagiokos Application of proteomics for the identification of differentially expressed protein markers for down syndrome in maternal plasma Prenat Diagn 28 8 2008 691 698
58. U. Pecks, F. Seidenspinner, C. Rower, T. Reimer, W. Rath, and M.O. Glocker Multifactorial analysis of affinity-mass spectrometry data from serum protein samples: a strategy to distinguish patients with preeclampsia from matching control individuals J Am Soc Mass Spectrom 21 10 2010 1699 1711
59. J.C. Heitner, C. Koy, M. Kreutzer, B. Gerber, T. Reimer, and M.O. Glocker Differentiation of HELLP patients from healthy pregnant women by proteome analysis-on the way towards a clinical marker set J Chromatogr B Analyt Technol Biomed Life Sci 840 1 2006 10 19
60. V. Kolla, P. Jeno, S. Moes, S. Tercanli, O. Lapaire, and M. Choolani Quantitative proteomics analysis of maternal plasma in down syndrome pregnancies using isobaric tagging reagent (iTRAQ) J Biomed Biotechnol 2010 2010 952047
61. M. Blumenstein, M.T. McMaster, M.A. Black, S. Wu, R. Prakash, and J. Cooney A proteomic approach identifies early pregnancy biomarkers for preeclampsia: novel linkages between a predisposition to preeclampsia and cardiovascular disease Proteomics 9 11 2009 2929 2945